Treatment of hemophilia: a review of current advances and ongoing issues

Replacement of the congenitally deficient factor VIII or IX through plasma-derived or recombinant concentrates is the mainstay of treatment for hemophilia. Concentrate infusions when hemorrhages occur typically in joint and muscles (on-demand treatment) is able to resolve bleeding, but does not prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppola, Antonio, Di Capua, Mirko, Di Minno, Matteo Nicola Dario, Di Palo, Mariagiovanna, Marrone, Emiliana, Ieranò, Paola, Arturo, Claudia, Tufano, Antonella, Cerbone, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262316/
https://www.ncbi.nlm.nih.gov/pubmed/22282697
http://dx.doi.org/10.2147/JBM.S6885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262316/
https://www.ncbi.nlm.nih.gov/pubmed/22282697
http://dx.doi.org/10.2147/JBM.S6885

Ejemplares similares